Search company, investor...

Predict your next investment

Smith & Nephew company logo
Corporation
HEALTHCARE | Medical Devices & Equipment / Surgical Devices
smith-nephew.com

Investments

6

Portfolio Exits

2

Partners & Customers

10

Service Providers

1

About Smith & Nephew

Smith & Nephew (NYSE:SNN) is a British medical equipment manufacturing company. It is an international producer of advanced wound management products, arthroscopy products, trauma and clinical therapy products, and orthopedic reconstruction products.

Headquarters Location

5 Hatters Lane

Watford, England, WD18 8YE,

United Kingdom

+44 (0)20 7401 7646

Want to inform investors similar to Smith & Nephew about your company?

Submit your Analyst Briefing to get in front of investors, customers, and partners on CB Insights’ platform.

Research containing Smith & Nephew

Get data-driven expert analysis from the CB Insights Intelligence Unit.

CB Insights Intelligence Analysts have mentioned Smith & Nephew in 2 CB Insights research briefs, most recently on Jul 9, 2021.

Latest Smith & Nephew News

Combined Sales of Anti-biofilm Wound Dressing is expected to reach US$ 1939.45 million by 2033

Mar 15, 2023

Combined Sales of Anti-biofilm Wound Dressing is expected to reach US$ 1939.45 million by 2033 The net worth of the market share of the  anti-biofilm wound dressing  is predicted to reach from US$ 782.60 million in 2023 to over US$ 1939.45 million by 2033, recording a CAGR of 9.5% between 2023 and 2033. Incidence rates for chronic and acute wounds are expected to increase which is, driving demand for anti-biofilm wound dressings. Besides antimicrobial resistance and unhealthy sedentary lifestyles, tobacco and alcohol consumption contribute to the rising non-communicable disease burden. This is because chronic diseases such as diabetes, cancer, and other autoimmune diseases become more prevalent. Get Latest Sample Copy@  https://www.futuremarketinsights.com/reports/sample/rep-gb-16474 There are also several other factors contributing to the market’s growth, including the development of healthcare infrastructure across developing countries, and technological advancements in wound management. The efforts made by healthcare providers and key players to make wound care more popular. “Telehealth has played a key role in the strong recovery of the wound care market. Various healthcare providers have developed telehealth platforms to effectively manage patients with chronic and acute wounds.” says a lead analyst at Future Market Insights. Key Takeaways from Market Study The market for anti-biofilm wound dressing is expected to record a CAGR of 9.5% over the forecast period. According to estimates, the anti-biofilm wound dressing market in North America may remain strong throughout the length of the forecast period. Acute wound segment dominated the market and is expected to record a CAGR of 9.3%. Ask An Analyst @  https://www.futuremarketinsights.com/ask-question/rep-gb-16474 Competitive Landscape: Several prominent companies dominate this market, including ConvaTec, Smith & Nephew PLC, Urgo Medical, Coloplast, and 3M. Anti-biofilm wound dressing has developed significantly in the industry through partnerships, acquisitions, and research and development. These strategies have resulted in major developments. Recent Developments: Convatec Inc. acquired Triad Life Sciences Inc. in March 2022 for US$ 450 million. This acquisition was made with the aim of strengthening its portfolio of biomedical products for surgical wounds and chronic wounds. The FDA cleared an antimicrobial matrix product made by Imbed Biosciences, Microlyte Matrix, in April 2021. The product can be used to treat surgical, traumatic, and chronic wounds. For the treatment of diabetic foot ulcers, pressure ulcers, leg ulcers, and dehisced surgical wounds, ConvaTec Group Plc (ConvaTec) launched a new medication called “ConvaMax” in January 2020. As well as adhesion-free options, the product is also available in non-adhesive forms, allowing for total flexibility when it comes to integrating compression bands and other main dressings. In January 2018, Imbed Biosciences introduced the market with Microlyte Ag after raising over US$ 1.6 million to research silver-based anti-biofilm wound dressings. As a result of this acquisition, Smith & Nephew PLC expanded its product portfolio for advanced wound management, increasing its market share and customer base. In April 2019, the company acquired Osiris Therapeutics, Inc., a regenerative medicine company. As a result of this acquisition, the company will boost its growth by expanding its product portfolio for advanced wound management.

Smith & Nephew Investments

6 Investments

Smith & Nephew has made 6 investments. Their latest investment was in MIACH Orthopaedics as part of their Series B on January 1, 2023.

CBI Logo

Smith & Nephew Investments Activity

investments chart

Date

Round

Company

Amount

New?

Co-Investors

Sources

1/25/2023

Series B

MIACH Orthopaedics

$30M

Yes

5

1/14/2019

Series C - II

Subscribe to see more

$99M

Subscribe to see more

10

6/6/2017

Series C

Subscribe to see more

$99M

Subscribe to see more

10

12/1/2016

Series B

Subscribe to see more

$99M

Subscribe to see more

10

5/19/2015

Series A

Subscribe to see more

$99M

Subscribe to see more

10

Date

1/25/2023

1/14/2019

6/6/2017

12/1/2016

5/19/2015

Round

Series B

Series C - II

Series C

Series B

Series A

Company

MIACH Orthopaedics

Subscribe to see more

Subscribe to see more

Subscribe to see more

Subscribe to see more

Amount

$30M

$99M

$99M

$99M

$99M

New?

Yes

Subscribe to see more

Subscribe to see more

Subscribe to see more

Subscribe to see more

Co-Investors

Sources

5

10

10

10

10

Smith & Nephew Portfolio Exits

2 Portfolio Exits

Smith & Nephew has 2 portfolio exits. Their latest portfolio exit was OrthoSpace on March 14, 2019.

Date

Exit

Companies

Valuation
Valuations are submitted by companies, mined from state filings or news, provided by VentureSource, or based on a comparables valuation model.

Acquirer

Sources

3/14/2019

Acquired

$99M

3

5/19/2016

Divestiture

Subscribe to see more

$99M

Subscribe to see more

10

Date

3/14/2019

5/19/2016

Exit

Acquired

Divestiture

Companies

Subscribe to see more

Valuation

$99M

$99M

Acquirer

Subscribe to see more

Sources

3

10

Smith & Nephew Acquisitions

23 Acquisitions

Smith & Nephew acquired 23 companies. Their latest acquisition was Engage Surgical on January 19, 2022.

Date

Investment Stage

Companies

Valuation
Valuations are submitted by companies, mined from state filings or news, provided by VentureSource, or based on a comparables valuation model.

Total Funding

Note

Sources

1/19/2022

$99M

Acquired

8

9/29/2020

$99M

Acquired Unit

7

1/24/2020

Debt

$99M

$53.54M

Acquired

1

7/1/2019

Subscribe to see more

$99M

Subscribe to see more

10

6/11/2019

Subscribe to see more

$99M

Subscribe to see more

10

Date

1/19/2022

9/29/2020

1/24/2020

7/1/2019

6/11/2019

Investment Stage

Debt

Companies

Subscribe to see more

Subscribe to see more

Valuation

$99M

$99M

$99M

$99M

$99M

Total Funding

$53.54M

Note

Acquired

Acquired Unit

Acquired

Subscribe to see more

Subscribe to see more

Sources

8

7

1

10

10

Smith & Nephew Partners & Customers

10 Partners and customers

Smith & Nephew has 10 strategic partners and customers. Smith & Nephew recently partnered with GCX on August 8, 2021.

Date

Type

Business Partner

Country

News Snippet

Sources

8/2/2021

Partner

United States

GCX Medical Mounting Solutions Collaborating with Smith Nephew on a… Collaborating with Smith+Nephew on a Surgical Robotics Cart. August 2, 2021 by Angel Merino, OEM Regional Sales Manager in Medical Devices , Mobile Devices.

The company knew from the partnership 's start that GCX would `` own '' product quality , which meant Smith + Nephew could deliver their new robotic cart solution for the CORI System to customers within a cost-effective package .

1

3/26/2021

Licensor

Italy

Smith+Nephew to add Movendo’s robotic rehabilitation capability to Real Intelligence ecosystem

Smith + Nephew has collaborated with Movendo Technology to add the personalised robotic patient rehabilitation capability to its Real Intelligence digital ecosystem .

1

3/3/2021

Partner

United Kingdom

1

3/3/2021

Partner

United Kingdom

Subscribe to see more

Subscribe to see more

10

2/1/2021

Partner

United States

Subscribe to see more

Subscribe to see more

10

Date

8/2/2021

3/26/2021

3/3/2021

3/3/2021

2/1/2021

Type

Partner

Licensor

Partner

Partner

Partner

Business Partner

Country

United States

Italy

United Kingdom

United Kingdom

United States

News Snippet

GCX Medical Mounting Solutions Collaborating with Smith Nephew on a… Collaborating with Smith+Nephew on a Surgical Robotics Cart. August 2, 2021 by Angel Merino, OEM Regional Sales Manager in Medical Devices , Mobile Devices.

The company knew from the partnership 's start that GCX would `` own '' product quality , which meant Smith + Nephew could deliver their new robotic cart solution for the CORI System to customers within a cost-effective package .

Smith+Nephew to add Movendo’s robotic rehabilitation capability to Real Intelligence ecosystem

Smith + Nephew has collaborated with Movendo Technology to add the personalised robotic patient rehabilitation capability to its Real Intelligence digital ecosystem .

Subscribe to see more

Subscribe to see more

Subscribe to see more

Subscribe to see more

Sources

1

1

1

10

10

Smith & Nephew Service Providers

1 Service Provider

Smith & Nephew has 1 service provider relationship

Service Provider

Associated Rounds

Provider Type

Service Type

Acq - P2P

Investment Bank

Financial Advisor

Service Provider

Associated Rounds

Acq - P2P

Provider Type

Investment Bank

Service Type

Financial Advisor

Partnership data by VentureSource

Smith & Nephew Team

41 Team Members

Smith & Nephew has 41 team members, including current Chief Executive Officer, Christoper O'Donnell.

Name

Work History

Title

Status

Christoper O'Donnell

Chief Executive Officer

Current

Subscribe to see more

Subscribe to see more

Subscribe to see more

Subscribe to see more

Subscribe to see more

Subscribe to see more

Subscribe to see more

Subscribe to see more

Subscribe to see more

Subscribe to see more

Subscribe to see more

Subscribe to see more

Name

Christoper O'Donnell

Subscribe to see more

Subscribe to see more

Subscribe to see more

Subscribe to see more

Work History

Title

Chief Executive Officer

Subscribe to see more

Subscribe to see more

Subscribe to see more

Subscribe to see more

Status

Current

Subscribe to see more

Subscribe to see more

Subscribe to see more

Subscribe to see more

Compare Smith & Nephew to Competitors

Arthrex Logo
Arthrex

Arthrex is a global medical device company that specializes in new product development and medical education in orthopedics.

M
Medrobotics

Medrobotics has developed a platform of flexible medical robots that enable surgeons to access, visualize, and perform two-handed surgery in hard-to-reach anatomical places through a single-site access. The core technology is a new generation of flexible robotic snakes with advanced vision systems that are able to navigate tortuous paths while providing accessory channels for a wide range of flexible surgical tools. The robots are self-supporting, which means they are able to support their own weight and move within any three-dimensional space without the need for any other structural support. The company was formerly known as Cardiorobotics and Innvoention Technologies.

Quantum Surgical Logo
Quantum Surgical

Quantum Surgical is a surgical robotics start-up building next-generation smart tools for minimally invasive therapies, beginning with interventional oncology. The robotic platform will enable physicians to better assess, plan, and treat a broad spectrum of medical conditions. The Company is developing end-to-end solutions for interventional oncology.

nView medical Logo
nView medical

nView medical develops imaging technology — bringing AI solutions for image creation, image processing, and image visualization to surgery and interventional radiology.

Nela Biodynamics Logo
Nela Biodynamics

Nela Biodynamics offers a novel modular system for intramedullary implants with a wide range of applications.

B
Biomendex

Biomendex develop and manufacture adaptable synthetic bone substitute materials for bone regeneration. Adaptos is a bioactive bone graft substitute that surgeons can cut, shape or squeeze into place.

Discover the right solution for your team

The CB Insights tech market intelligence platform analyzes millions of data points on vendors, products, partnerships, and patents to help your team find their next technology solution.

Request a demo

CBI websites generally use certain cookies to enable better interactions with our sites and services. Use of these cookies, which may be stored on your device, permits us to improve and customize your experience. You can read more about your cookie choices at our privacy policy here. By continuing to use this site you are consenting to these choices.